Entecavir plus Fuzheng Huayu Compound Reduces the Risk of Portal Hypertension-related Complications in Patients with Compensated Hepatitis B Virus-related Cirrhosis: A Post Hoc Analysis Based on Two Randomized Controlled Trials
Yanan Guo, Li Du, Qing Xie, Chuan Liu, Lianjun Xing, Wei Jiang, Bitao Chen, Ying Zhu, Xiaorong Chen, Jing Wang, Xiaolong Qi, Jing Lv, Chenghai Liu
